Mepolizumab therapy for eosinophilic granulomatosis with polyangiitis (EGPA)-one year follow-up study using anti-IL5 as a steroid sparing therapeutic approach

Category Primary study
JournalNephrology Dialysis Transplantation
Year 2020
This article has no abstract
Epistemonikos ID: a08a9e8b784b5dd7d6f9f9374f0de8271aa2ac2b
First added on: Feb 12, 2025